How a New SCOTUS Ruling Could Affect Pharma ETFs

The VanEck Vectors Generic Drugs ETF (NasdaqGM: GNRX) traded slightly higher Tuesday after the U.S. Supreme Court issued what some industry observers are calling a mixed ruling on expediting the availability of lower-cost equivalents to high-priced biotechnology drugs. “The justices said patent holders can’t use federal law to enforce a requirement that companies seeking to…Click to read more at